Risk factor
Very high price volatility
Profitability factor
Strong growth
About
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.
Target Price
The average target price of MDAI is 4.6 and suggests 147% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell